Unisense FertiliTech A/S Secures an Additional 20 Million USD in New Capital Investment

Aarhus, Denmark (ots/PRNewswire) -

Danish medtech company Unisense FertiliTech A/S announces a new
partnership with the Danish Pension Fund PKA. PKA owns 25% of
Unisense FertiliTech A/S after the purchase of shares in the company
worth 20 million USD. This brings the total of new investment in the
company over the past 3 months to 45 million USD.

Unisense FertiliTech A/S develops and manufactures products to
improve treatment in the field of assisted reproduction. The company
has expanded rapidly in the past 2 years, operating in more than 30
countries worldwide. In addition to the current hardware and software
product offerings, there is an exciting pipeline of products under
development which hold significant commercial potential within the
IVF industry. With this additional investment, the company will be in
an excellent position to execute its long term development strategy
and to accelerate the global expansion of sales of FertiliTech's
existing and new products geared towards improving clinical practice
in the field of IVF.

Investment Director at PKA, Michael Nellemann Pedersen states
"FertiliTech has created a unique product with a rapidly growing
global demand. This demand is expected to continue, with a worldwide
increased trend to a higher age of first time mothers. We feel this
is an extremely exciting investment opportunity with a promising
future."

"We very much look forward to the cooperation with PKA, who with
this long term investment contributes positively to create stability
in the ownership of Unisense FertiliTech," says Unisense FertiliTech
A/S CEO, Jens Gundersen.

About Unisense FertiliTech A/S

Unisense FertiliTech A/S was founded in 2003 and has developed and
manufactures state-of-the-art instrumentation in the field of IVF.
The current products include the EmbryoScope(R) Time-lapse system,
the EmbryoViewer(R) Software and related accessory products, which
are EU approved and FDA cleared for clinical use in IVF laboratories.
Unisense FertiliTech A/S conforms to the requirements in DS/EN ISO
13485:2012 for production, installation and servicing of IVF
incubators and related accessories

The company is involved in numerous international collaborations,
and strives to develop embryo assessment algorithms to improve embryo
selection and workflow in the assisted reproduction laboratory. Our
goal is to promote knowledge building through extensive documentation
and retrospective analysis. We are dedicated to providing technology
to improve IVF treatment through quantification of embryo development
patterns.

About PKA:

PKA is a joint administration for five Danish pension funds with a
total of 250,000 members. They control funds of USD 35 billion.

Website: http://www.fertilitech.com

ots Originaltext: Unisense FertiliTech A/S
Im Internet recherchierbar: http://www.presseportal.de

Contact:
For further information : Please contact: +45-89449500, Jens
Gundersen CEO jkg@fertilitech.com, Michael Reeslev CFO
mkr@fertilitech.com